Circadian Regulation of Microglial Function in Alzheimer\u27s Disease by Nadarajah, Collin Joseph
Washington University in St. Louis 
Washington University Open Scholarship 
Volume 12 Washington University Undergraduate Research Digest 
Spring 2017 
Circadian Regulation of Microglial Function in Alzheimer's 
Disease 
Collin Joseph Nadarajah 
Washington University in St. Louis 
Follow this and additional works at: https://openscholarship.wustl.edu/wuurd_vol12 
Recommended Citation 
Nadarajah, Collin Joseph, "Circadian Regulation of Microglial Function in Alzheimer's Disease" (2017). 
Volume 12. 145. 
https://openscholarship.wustl.edu/wuurd_vol12/145 
This Abstracts J-R is brought to you for free and open access by the Washington University 
Undergraduate Research Digest at Washington University Open Scholarship. It has been accepted for inclusion in 
Volume 12 by an authorized administrator of Washington University Open Scholarship. For more information, 
please contact digital@wumail.wustl.edu. 
Toward a Better Understanding of...
188
Circadian Regulation of Microglial Function 
in Alzheimer’s Disease
Collin Joseph Nadarajah
Mentor: Erik Musiek
Alzheimer’s Disease (AD) is the most common form of dementia and carries age as its 
number one risk factor. Neuronal damage caused by inflammation and oxidative stress 
are consistent hallmarks of AD. Microglia, the chief immune cells of the central nervous 
system, are principal contributors to, and under certain conditions can exacerbate, these 
effects. Furthermore, disruption of circadian rhythms and the molecular clock of CNS 
cells have been linked to the development and progression of AD.  Thus, investigating 
circadian rhythm dysfunction in microglia and its impact on AD could elucidate the role 
of microglia in the neurodegeneration seen in AD.
To disrupt the microglial circadian clock, we used a microglial specific (Cx3cr1-
linked) Cre recombinase to excise and knock out microglial Bmal1, a core clock gene, 
causing total loss of microglial molecular clock rhythms throughout the CNS. This Cre 
lineage was crossed to AD model mice (PS1/APP transgenic) and all mice were aged to 
16-18 months. We quantified gene expression of various inflammatory and oxidative 
stress markers in cortical tissue via RT-qPCR. We then measured astrocyte and microglial 
activation and evaluated amyloid beta (Aβ) plaque load via immunohistological staining 
of brain tissue slices. In the PS1/APP-Cre+ mice, there was elevated expression of 
cytochrome b-245, beta chain (Cybb or NOX2), an oxidative stress marker, relative to 
that of the PS1/APP-Cre- mice. This suggests a potential role for the microglial circadian 
clock in regulating the oxidative stress response in AD.
